Hubertus von Baumbach

Chairman of the Board of Managing Directors and Chief Executive Officer, Boehringer Ingelheim

Hubertus von Baumbach has been Chairman of the Board of Managing Directors and Chief Executive Officer of Boehringer Ingelheim since July 2016. He also holds the position as Chairman of the Family Board.

Prior to being appointed Chairman of the Board, Mr. von Baumbach served as Chief Financial Officer since 2009 and previously held multiple leadership positions within Boehringer Ingelheim. He started his professional career in 1988 in the US affiliate of F. Hoffmann – La Roche AG in Nutley, New Jersey.

Mr. von Baumbach was trained as a bank clerk at Merck, Finck & Co. in Munich, received his law degree from the Ludwig-Maximilians-Universität in Munich, took the German Bar Exam, and received a MBA from Sloan School of Management at Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts.

Mr. von Baumbach serves as a Member on Boards and Advisory Boards of several industrial companies, foundations and industry associations, including as President of the association of the European research-driven pharmaceutical industry (efpia).

Boehringer Ingelheim, an independent and family-owned company founded in 1885, develops, produces and distributes innovative medicines for humans and animals. This gives Boehringer Ingelheim the freedom to pursue a long-term vision to medicine, looking ahead to identify the health challenges of the future. Its mission is to create breakthrough therapies where the medical need is high.